Bill Summary
H.R. 7050 amends the Federal Food, Drug, and Cosmetic Act to create a distinct regulatory framework for homeopathic drug products. It defines homeopathic drugs by reference to the Homeopathic Pharmacopoeia of the United States and related standards, then tailors which federal drug provisions apply to them. The bill focuses regulation on adulteration, misbranding, manufacturing quality, and establishment registration, while barring premarket approval requirements for homeopathic products and recognizing traditional homeopathic indications when paired with an FDA disclaimer. It also establishes a Homeopathic Drug Product Advisory Committee, withdraws existing FDA guidance on homeopathic products, and clarifies that it does not override state laws governing the practice of homeopathy.
H.R. 7050 amends the Federal Food, Drug, and Cosmetic Act to create a distinct regulatory framework for homeopathic drug products. It defines homeopathic drugs by reference to the Homeopathic Pharmacopoeia of the United States and related standards, then tailors which federal drug provisions apply to them. The bill focuses regulation on adulteration, misbranding, manufacturing quality, and establishment registration, while barring premarket approval requirements for homeopathic products and recognizing traditional homeopathic indications when paired with an FDA disclaimer. It also establishes a Homeopathic Drug Product Advisory Committee, withdraws existing FDA guidance on homeopathic products, and clarifies that it does not override state laws governing the practice of homeopathy.
Why It Matters to the Make America Healthy Again Movement
The MAHA Movement supports this bill because it protects access to homeopathic medicines while demanding clear quality standards and honest labeling. By shielding homeopathic products from being regulated like conventional pharmaceuticals, H.R. 7050 preserves a key non-pharmacologic option for families seeking gentler, low-risk remedies and more control over their health choices.